Psychedelic therapies and belief change: are there risks of epistemic harm or epistemic injustice?
M. Zeller
Philosophical Psychology June 3, 2024 DOI: 10.1080/09515089.2024.2362284 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Key points | Argues that accusations of epistemic harm from metaphysical beliefs in psychedelic-assisted psychotherapies may constitute epistemic injustice, and that fostering such beliefs is likely benign if therapeutic outcomes are prioritized. |
Abstract
ABSTRACT Psychedelic-assisted psychotherapies (PAPs) have shown promise in treating mental health disorders, but concerns persist regarding their potential to elicit “false beliefs” through altered states of consciousness. Some argue that metaphysical or mystical beliefs conflicting with philosophical naturalism could signify “epistemic harm” in patients. We contend that such accusations may conceal a form of epistemic injustice by disqualifying non-naturalistic beliefs under a presumption of epistemic superiority, compromising the validation of pathologized subjective states. We argue that fostering exotic metaphysical beliefs in PAPs could be considered epistemically and medically benign, with the primary focus on generating positive mental health outcomes rather than instilling specific metaphysical convictions. We explore the capacity of PAPs to modify beliefs, examine allegations of epistemic harm and injustice, adresse the “comforting delusion” objection, and discuss the importance of respecting patients’ epistemic agency and cognitive liberty. We contrast philosophical naturalism with epistemic pluralism, advocating for the latter in PAPs. Finally we discuss implications for the future of psychedelic research and therapy, emphasizing the need to prioritize therapeutic outcomes over the specific beliefs elicited.
Citations in the library
Cited by 3
- Comforting delusions? How to evaluate the plausibility of mystical-type insights in psychedelic experiences Philosophical Psychology August 14, 2024
- Therapeutic benefit versus epistemic risk: Need for empirical research in psychedelic epistemology. Journal of Psychiatric Research August 1, 2025
- Psychedelic Ethics Philosophy Compass September 1, 2025
Cites 70
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
and 65 more in the library